INTERNATIONAL PATENT: UNIQURE BIOPHARMA B.V. FILES APPLICATION FOR "NUCLEIC ACID REGULATION OF MSH3 IN REPEAT EXPANSION DISORDERS"

GENEVA, April 19 -- UNIQURE BIOPHARMA B.V. (Paasheuvelweg 251105 BP Amsterdam) filed a patent application (PCT/EP2024/078684) for "NUCLEIC ACID REGULATION OF MSH3 IN REPEAT EXPANSION DISORDERS" on Oct 11, 2024. With publication no. WO/2025/078602, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VAN DER BENT, Melanie Leontien (c/o uniQure biopharma B.V. Paasheuvelweg 251105 BP Amsterdam), VALLES SANCHEZ, Astrid (c/o uniQure biopharma B.V. Paasheuvelweg 251105 BP Amsterdam)

Abstract: The present invention relates to nucl...